background
porcin
produc
host
cell
antimicrobi
cysteinerich
cation
peptid
multifunct
previou
studi
demonstr
kill
variou
bacteria
regul
host
immun
respons
promot
growth
piglet
howev
antivir
role
rare
investig
studi
aim
reveal
antivir
abil
pseudorabi
viru
prv
caus
pathogen
aujeszki
diseas
cell
express
transgen
tg
mous
model
method
studi
cytotox
cell
measur
assay
cell
incub
prv
pretreat
differ
concentr
prv
titer
cell
cultur
supernat
determin
realtim
quantit
pcr
rtqpcr
tg
mice
wildtyp
wt
mice
intraperiton
inject
prv
surviv
rate
record
day
meanwhil
tissu
lesion
brain
spleen
liver
infect
mice
observ
viral
load
prv
brain
liver
lung
analyz
rtqpcr
result
maximum
concentr
display
signific
cytotox
cell
threshold
concentr
requir
inhibit
prv
prolifer
cell
surviv
rate
tg
mice
higher
wt
mice
addit
tg
mice
show
allevi
tissu
lesion
brain
spleen
liver
compar
wt
litterm
prv
challeng
viral
load
prv
brain
liver
lung
tg
mice
significantli
lower
wt
mice
conclus
could
inhibit
prv
prolifer
cell
protect
mice
prv
infect
confirm
antivir
abil
vitro
vivo
applic
develop
antivir
drug
diseaseresist
anim
investig
defensin
group
cation
microbicid
peptid
constitut
amino
acid
three
intramolecular
disulfid
bond
form
pair
conserv
cystein
residu
defensin
vertebr
subdivid
defensin
base
spatial
structur
disulfid
connect
within
pig
defensin
subfamili
defensin
character
far
porcin
first
determin
sequenc
align
exist
sequenc
porcin
identifi
distribut
differ
pig
tissu
use
polyclon
antibodi
antimicrobi
activ
gramposit
gramneg
bacteria
well
describ
also
exhibit
immunomodulatori
properti
recent
research
demonstr
could
allevi
inflamm
interact
tolllik
receptor
suppress
downstream
signal
pathway
addit
found
attenu
prolifer
porcin
reproduct
respiratori
syndrom
viru
prrsv
cell
molecular
dock
evalu
reveal
peptid
deriv
potenti
use
inhibit
hepat
e
viru
interact
capsid
protein
howev
effect
viru
prolifer
vivo
remain
unknown
pseudorabi
viru
prv
envelop
doublestrand
dna
herpesviru
etiolog
pathogen
aujeszki
diseas
caus
meningoenceph
paravertebr
ganglioneur
pig
vaccin
brought
china
hungari
prevent
prv
infect
led
success
control
prv
sinc
howev
prv
variant
pig
result
resurg
prv
preval
china
sinc
late
china
infect
rate
still
requir
effort
achiev
erad
prv
addit
vaccin
develop
studi
novel
strategi
combat
prv
also
great
signific
basi
amino
acid
sequenc
align
molecular
biolog
analys
prv
resembl
alphaherpesvirus
within
famili
alphaherpesvirina
antivir
abil
defensin
alphaherpesvirus
describ
previous
antivir
abil
herp
simplex
viru
hsv
infect
character
human
neutrophil
peptid
hnp
human
hd
rabbit
term
human
hbd
synthet
analog
constitut
domain
confirm
inactiv
hsv
bovin
neutrophil
found
show
inhibitori
activ
bovin
herp
viru
besid
report
inhibit
varicella
zoster
viru
infect
retrocyclin
rhesu
defensin
belong
found
suppress
hsv
infect
therefor
util
defensin
drug
target
gene
gener
diseaseresist
anim
may
use
control
viru
infect
although
swine
serv
natur
host
reservoir
prv
mice
often
util
prefer
model
organ
studi
prv
infect
suscept
prv
studi
effect
prolifer
prv
investig
cell
transgen
tg
mice
gener
previou
studi
result
confirm
effect
suppress
viru
prolifer
provid
novel
idea
control
prv
infect
prv
strain
ea
isol
hubei
provinc
china
use
studi
porcin
cell
maintain
dulbecco
modifi
eagl
medium
thermo
fisher
scientif
waltham
usa
supplement
fetal
bovin
serum
fb
thermo
fisher
scientif
atmospher
co
cell
use
propag
prv
briefli
viru
stock
ad
cell
reach
confluenc
cell
cultur
flask
h
remov
viru
inoculum
ml
mainten
medium
ad
cytopath
effect
cpe
present
cell
harvest
repeatedli
freezethaw
centrifug
prv
obtain
supernat
titrat
prv
measur
calcul
use
reedmuench
method
accord
protocol
describ
previous
cell
count
dojindo
shanghai
china
assay
use
determin
cell
viabil
accord
manufactur
instruct
briefli
cell
suspens
cellswel
inocul
plate
h
cultur
cell
attach
bottom
plate
differ
concentr
rang
subsequ
ad
plate
without
presenc
fb
cell
coincub
h
ad
solut
anoth
threehour
incub
absorb
measur
nm
use
micropl
reader
tecan
switzerland
cell
viabil
control
absorb
test
sampl
absorb
blank
absorb
control
absorb
blank
synthet
matur
peptid
dhyicakkggtcnfspcplfnriegtcysgkakccir
chinapeptid
shanghai
china
use
evalu
antivir
activ
prv
prv
stock
dilut
dpb
preincub
differ
concentr
h
mixtur
ad
plate
cell
well
moi
plate
incub
anoth
h
inoculum
discard
well
wash
pb
ad
fresh
mainten
medium
h
cell
cultur
supernat
collect
viral
dna
isol
use
quickdnarna
viral
kit
zymo
research
irvin
ca
usa
result
viral
dna
subject
realtim
quantit
pcr
rtqpcr
along
standard
plasmid
plasmid
contain
glycoprotein
gd
gene
highli
conserv
gene
prv
serial
dilut
subject
rtqpcr
gener
standard
curv
use
primer
amplifi
part
gd
gene
bp
length
number
prv
copi
determin
standard
curv
convert
correspond
ct
valu
mice
group
viabil
test
prv
infect
tg
mice
express
gener
lab
previous
genom
dna
mous
tail
sampl
extract
use
identif
tg
mice
express
use
primer
week
age
tg
mice
n
weigh
g
intraperiton
inject
ml
prv
tcid
ml
wildtyp
wt
litterm
n
treat
amount
prv
surviv
assess
two
group
mice
daili
day
tg
wt
mice
intraperiton
inject
ml
prv
tcid
ml
sacrif
day
postinfect
brain
spleen
liver
lung
harvest
analys
dna
mg
brain
liver
lung
tissu
extract
use
ezna
tissu
dna
kit
omega
biotek
norcross
ga
usa
accord
manufactur
instruct
prv
copi
total
dna
tissu
sampl
measur
rtqpcr
calcul
describ
brain
spleen
liver
tissu
tg
wt
mice
fix
pbsbuffer
formaldehyd
h
tissu
embed
paraffin
slice
section
thick
section
subject
haematoxylin
eosin
stain
tissu
lesion
observ
microscop
statist
analys
perform
graphpad
prism
graphpad
softwar
la
jolla
ca
usa
use
unpair
onetail
student
ttest
shown
mean
sd
p
p
p
p
cytotox
evalu
use
assay
cell
viabil
analysi
indic
display
signific
cytotox
cell
maximum
concentr
minimum
concentr
fig
differ
concentr
use
assess
antivir
effect
prv
cell
compar
prv
without
pretreat
signific
reduct
viral
titer
observ
prv
preincub
p
fig
result
indic
rel
high
concentr
could
significantli
inhibit
prv
prolifer
cell
without
cytotox
activ
antivir
effect
surviv
mice
infect
prv
investig
wt
mice
intraperiton
infect
ml
prv
tcid
ml
show
surviv
rate
express
increas
surviv
rate
tg
mice
fig
thu
result
reveal
tg
mice
express
resist
prv
infect
control
mice
prv
genom
copi
number
quantifi
brain
liver
lung
tissu
tg
wt
mice
infect
prv
rtqpcr
prv
viral
load
brain
tissu
tg
mice
wt
mice
higher
liver
lung
tissu
howev
prv
viral
load
brain
p
liver
p
lung
p
tg
mice
significantli
lower
wt
mice
fig
henc
could
significantli
depress
viral
load
prv
differ
tissu
patholog
chang
wt
mice
tg
mice
prv
infect
also
detect
microglia
nodul
associ
neuron
degener
necrosi
observ
brain
tissu
wt
mice
fig
neuron
swell
dissolut
nissl
bodi
basophil
inclus
present
tg
mice
fig
besid
necrosi
cell
found
spleen
tissu
wt
mice
fig
tg
mice
show
slight
hyperemia
spleen
fig
degener
cell
congest
liver
wt
mice
observ
fig
appar
lesion
tg
mice
fig
togeth
result
demonstr
tg
mice
display
milder
tissu
lesion
wt
mice
prv
infect
impact
viral
pathogen
well
examin
experiment
yet
previou
studi
show
exhibit
antivir
abil
prrsv
concentr
reach
similarli
studi
ml
found
inhibit
prv
prolifer
cell
signific
effect
observ
lower
concentr
fig
indic
threshold
concentr
requir
inhibit
viral
prolifer
accord
surviv
detect
viru
copi
patholog
chang
tg
mice
display
significantli
increas
resist
prv
infect
compar
wt
mice
therefor
antivir
effect
confirm
cell
tg
mice
express
reveal
defensin
direct
inact
envelop
virus
disrupt
viral
lipid
bilay
studi
prv
preincub
use
infect
cell
accord
result
hypothes
might
direct
virucid
effect
prv
damag
viral
envelop
besid
may
also
affect
prv
entri
still
present
whole
process
viral
adsorpt
sinc
prv
share
high
structur
sequenc
similar
alphaherpesvirus
antivir
mechan
defensin
alphaherpesvirus
would
help
understand
inhibit
prv
prolifer
capabl
block
hsv
bind
interact
heparan
sulfat
primari
receptor
hsv
bind
enhanc
inhibitori
effect
hsv
bound
heparan
sulfat
gb
abl
prevent
viral
adhes
entri
hsv
bind
gb
gd
likewis
rabbit
inactiv
hsv
prevent
viral
entri
retrocyclin
prevent
hsv
bind
entri
intercellular
spread
bind
carbohydr
moieti
glycoprotein
b
gener
defensin
prevent
hsv
infect
block
viral
bind
penetr
whether
abl
block
viral
bind
penetr
interact
specif
host
membran
receptor
studi
total
dna
use
determin
prv
copi
number
obtain
brain
liver
lung
tissu
wt
tg
mice
n
group
day
prv
inject
data
present
mean
sd
plot
three
independ
experi
p
p
p
unpair
one
tail
ttest
correct
fig
histopatholog
analysi
brain
spleen
liver
tissu
tg
wt
mice
infect
prv
tissu
fix
formaldehyd
subsequ
embed
paraffin
section
stain
black
arrow
indic
histopatholog
damag
c
e
show
stain
brain
spleen
liver
tissu
repres
wt
mice
b
f
show
stain
brain
spleen
liver
tissu
repres
tg
mice
defensin
confirm
effect
resist
pathogen
chen
et
al
argu
higher
express
level
meishan
pig
crossbr
pig
confer
stronger
immun
meishan
pig
diseas
previou
studi
reveal
overexpress
pig
tg
mice
show
enhanc
resist
bacteri
infect
studi
verifi
tg
mice
display
increas
resist
viral
infect
thu
use
target
gener
diseaseresist
anim
bacteri
viral
infect
prv
import
pig
pathogen
still
present
china
japan
usa
european
countri
inhibitori
effect
vitro
vivo
discov
studi
provid
possibl
new
strategi
control
prv
overexpress
pig
tissu
transgen
mice
infect
prv
could
reduc
viral
load
allevi
tissu
lesion
differ
degre
differ
tissu
fig
previou
studi
discov
express
level
organ
differ
tg
mice
suggest
correl
express
level
antiprv
effect
differ
organ
worth
note
prv
load
brain
tissu
fig
highest
damag
brain
tissu
severest
fig
either
tg
mice
wt
mice
confirm
prv
distinct
tissu
tropism
herein
increas
express
anim
especi
brain
use
geneedit
techniqu
might
promot
resist
anim
prv
vivo
hand
may
use
drug
addit
vaccin
adjuv
develop
altern
strategi
control
prv
virus
attempt
use
control
viral
diseas
vivo
carri
express
zebrafish
fish
improv
resist
spring
viraemia
carp
viru
infect
applic
murin
dna
vaccin
adjuv
protect
mice
avian
influenza
virus
addit
mice
intranas
intratrach
inocul
deriv
mous
protect
infect
three
type
influenza
virus
sarsassoci
coronaviru
besid
intraperiton
inject
recombin
mous
mice
found
allevi
coxsackieviru
myocard
similarli
intraven
inject
improv
surviv
rate
mice
infect
influenza
viru
summari
within
studi
antivir
effect
vitro
vivo
confirm
use
prv
infect
model
techniqu
largescal
product
exist
transgen
pig
overexpress
creat
possibl
applic
novel
prophylact
therapeut
method
aujeszki
diseas
viral
diseas
addit
worthi
studi
underli
mechan
inhibitori
effect
prv
offer
insight
regard
antivir
effect
defensin
